<?xml version="1.0" encoding="UTF-8"?>
<svg height="766.066" width="538.8602127153846" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text svg_rhmargin="102.103" x="76.272,81.588,85.127,89.558,92.802,95.902,99.003,102.103" y="21.089000000000055" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">Cancers </text>
  <text x="104.096,108.081,112.066,116.051" y="21.089000000000055" svg_rhmargin="120.036" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:7.97px;font-style:NORMAL;font-weight:BOLD;">2019</text>
  <text svg_rhmargin="122.029" x="120.036,122.029" y="21.089000000000055" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="124.021,128.006" y="21.089000000000055" svg_rhmargin="131.991" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">11</text>
  <text x="131.991,133.984,135.976,139.961,143.94600000000003,491.809,495.794,499.779,501.772,506.123,508.777,510.77,514.755" y="21.089000000000055" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, 47 19 of 27</text>
  <text x="82.272,87.603,91.155,95.601,98.858,101.971,105.084,108.197" y="34.26800000000003" svg_rhmargin="110.192" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:7.98px;font-style:ITALIC;font-weight:normal;">Cancers </text>
  <text x="110.172,114.192,118.212,122.233" y="34.26800000000003" svg_rhmargin="126.223" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:7.98px;font-style:NORMAL;font-weight:bold;">2018</text>
  <text x="126.251,128.231" y="34.26800000000003" svg_rhmargin="130.226" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:7.98px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="130.211,134.231" y="34.26800000000003" svg_rhmargin="138.221" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:7.98px;font-style:ITALIC;font-weight:normal;">10</text>
  <text x="138.251,140.249,142.229,146.35,148.345,497.411,501.429,505.448,507.428,511.814,514.454,516.433,520.452,524.471" y="34.26800000000003" svg_rhmargin="526.466" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:7.98px;font-style:NORMAL;font-weight:normal;">, x 11 of 29 </text>
  <text style="fill:#000000;font-family:IKMAII+TimesNewRoman;font-size:9.0px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="84.522" y="426.668" x=""/>
  <text y="426.668" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="473.097" x=""/>
  <text x="103.512,108.535,111.533,116.538,122.038,125.54,130.04,132.29,132.86,137.361" y="442.988" svg_rhmargin="139.611" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:9.0px;font-style:NORMAL;font-weight:bold;">Figure 5.</text>
  <text style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:9.0px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="141.822" y="442.988" x=""/>
  <text x="142.392,147.915,153.16,157.419,159.669,160.239,163.179,168.101,171.662,175.979,179.801,182.742,184.992,185.561,190.977,193.557,198.477,201.418,205.199,207.449,208.019,212.939,215.88,218.13,218.64,226.562,230.882,233.822,238.328,241.332,244.893,249.21,254.189,257.75,262.068,265.89,269.712,272.338,277.199,282.419,284.669,285.238,289.745,294.989,299.495,302.12,307.099,310.94,313.566,317.348,319.604,321.854,322.364" y="442.988" svg_rhmargin="325.361" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.0px;font-style:NORMAL;font-weight:normal;">The forest plots of meta-regression analysis: (</text>
  <text x="325.332" y="442.988" svg_rhmargin="329.832" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:9.0px;font-style:NORMAL;font-weight:bold;">a</text>
  <text x="329.832,332.841,335.091,335.601,340.58,345.501,349.068,353.391,357.218,360.164,362.414,362.984,368.405,371.035,375.961,378.839,381.089,381.659,384.668,389.593,393.073,395.323,395.833,402.919,408.942,414.966,417.216,417.786,422.297,427.547,433.058,435.308,435.878,442.238,445.238,447.488,448.058,452.984,455.924,458.174,458.744,462.752,467.011,469.642,472.222,474.472,475.042,479.05,484.45,487.08,490.026,495.426,498.966,503.288" y="442.988" svg_rhmargin="505.538" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.0px;font-style:NORMAL;font-weight:normal;">) Forest plot for ORR and CI of cell culture </text>
  <text x="103.512,111.013,113.626,116.555,121.787,123.887,126.915,132.408,135.4,139.895,141.994,146.434,151.928,157.421,160.035,162.913,165.553,170.461,175.694,177.794,182.288,187.521,193.014,195.114,199.105,203.364,205.978,208.592,210.691,214.682,220.103,222.717,225.646,231.067,234.617,238.922,241.022,248.523,251.136,254.065,259.298,264.206,269.628,272.556,274.656,277.684,283.152,286.156,290.663,292.763,297.27,302.777,308.283,310.909,313.85,316.476,321.397,326.557,328.657,333.578,336.518,338.618,342.878,347.378,351.381,356.626,358.726,362.549,365.472,370.9,376.4,381.319,383.418,387.919,393.158,398.658,400.758,403.636,408.856,413.168,415.268,420.182,425.268,429.58,433.136,437.637,440.257,442.877,445.128,447.227" y="455.948" svg_rhmargin="450.224" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.0px;font-style:NORMAL;font-weight:normal;">with IL-2 addition and cell culture without IL-2 addition of each study and the overall; (</text>
  <text x="450.192" y="455.948" svg_rhmargin="455.691" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:9.0px;font-style:NORMAL;font-weight:bold;">b</text>
  <text x="455.712,458.676,460.717,465.688,470.609,474.132,478.452,482.293,485.232,487.331,492.731,495.37,500.291,503.23" y="455.948" svg_rhmargin="505.48" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.0px;font-style:NORMAL;font-weight:normal;">) Forest plot </text>
  <text x="103.512,106.508,111.421,114.975,117.225,118.096,124.476,130.487,136.498,138.748,139.618,144.117,149.354,154.853,157.103,157.973,164.353,167.385,169.635,170.505,175.418,178.415,180.665,181.535,184.468,189.705,193.965,196.215,197.085,200.018,204.931,207.864,212.363,214.982,217.232,218.102,222.542,228.063,236.009,238.627,243.864,246.482,250.298,253.231,256.785,261.284,264.217,266.835,271.748,276.985,279.235,280.045,285.543,290.456,294.272,298.582,300.832,301.702,309.648,314.561,318.115,322.425,324.675,325.546,328.479,333.716,338.156,343.376,345.626,346.496,350.995" y="469.027" svg_rhmargin="355.495" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.0px;font-style:NORMAL;font-weight:normal;">for CRR and CI of the total administration dose more than 10</text>
  <text x="355.512" y="466.508" svg_rhmargin="358.272" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:5.52px;font-style:NORMAL;font-weight:normal;">8</text>
  <text y="469.028" svg_rhmargin="447.806" x="361.392,365.38,369.683,372.294,374.905,378.713,380.963,381.833,386.325,391.555,397.046,399.296,400.166,402.777,407.08,410.888,414.696,416.946,417.816,420.742,425.972,430.464,435.694,437.944,438.814,443.306" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.0px;font-style:NORMAL;font-weight:normal;">cells and less than 10</text>
  <text x="447.852" y="466.508" svg_rhmargin="450.612" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:5.52px;font-style:NORMAL;font-weight:normal;">8</text>
  <text y="469.028" svg_rhmargin="505.48" x="453.672,457.634,461.954,464.59,467.226,471.008,473.258,474.128,479.059,482.073,484.323,485.194,489.522,493.961,497.974,503.23" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.0px;font-style:NORMAL;font-weight:normal;">cells of each </text>
  <text x="103.512,107.331,110.269,115.699,121.202,126.21,128.489,132.993,138.235,143.737,146.017,148.954,154.196,158.456,160.676,165.594,170.682,174.997,178.555,183.059,185.682,188.304" y="482.048" svg_rhmargin="190.554" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.0px;font-style:NORMAL;font-weight:normal;">study and the overall.</text>
  <text y="482.048" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:9.0px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="192.762" x=""/>
  <text x="82.272,87.276,89.775,92.235,100.555,103.886,108.329,112.711,118.827,123.27,127.713,131.043,136.608,142.67" y="507.188" svg_rhmargin="145.175" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:10.02px;font-style:NORMAL;font-weight:bold;">3. Discussion </text>
  <text x="103.512,111.292,115.524,118.029,122.364,127.819,133.635,138.418,140.923,145.318,150.773,154.093,156.59799999999998,160.993,164.244,170.059,174.843,177.34799999999998,181.743,190.574,196.029,200.262,203.44,205.945,210.34,216.346,220.287,225.742,234.574,237.514,241.775,244.715,250.475,256.03,258.53499999999997,262.93,266.18,270.122,274.906,279.9,283.15,291.982,296.765,302.581,305.831,310.033,312.538,316.932,320.292,325.753,329.68,332.185,336.58,339.758,345.818,354.635,360.074,364.001,368.219,370.693,373.198,377.592,380.828,389.154,394.593,397.098,401.493,407.033,409.973,415.774,421.865,426.082,428.587,432.982,438.422,441.727,444.23199999999997,448.627,455.647,463.449,470.111,472.616,477.011,483.122,485.627,490.022,493.257,499.058,503.826,507.753,512.732,518.723,524.361" y="526.688" svg_rhmargin="526.866" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">As one of the most promising treatments for tumors, two kinds of CAR T therapy </text>
  <text x="82.273,85.616,91.764,94.686,98.887,103.903,109.48,114.286,120.045,122.967,127.773,132.155,135.094,139.835,145.895,150.35,155.155,158.035,160.54,162.955,167.971,173.809,179.87,182.375,184.85,191.51,196.31,200.511,204.953,209.969,213.933,217.171,222.151,225.494,227.999,230.474,236.233,241.273,247.335,249.84,252.315,257.773,262.579,267.384,273.222,275.727,278.142,283.158,289.157,295.156,299.116,304.593,310.233,314.973,321.095,323.6,326.075,331.593,337.111,339.616,342.091,345.329,351.149,355.954,358.459,360.874,366.451,371.852,377.329,383.457,385.962,388.377,393.393,399.231,405.292,407.79699999999997,410.272,418.033,421.997,427.997,433.575,436.08,438.555,446.297,452.418,461.239,464.179,469.939,472.879,477.133,480.372,484.336,489.315,492.554,495.494,500.971,506.808,509.313,511.788,515.131,520.532,524.496" y="540.187" svg_rhmargin="527.001" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">(Tisagenlecleucel and Yescarta) had been approved by the Food and Drug Administration for </text>
  <text x="82.273,88.272,93.312,96.556,99.495,104.272,110.081,113.324,117.549,119.59,127.923,130.863,134.106,139.915,141.895,149.668,155.767,161.866,163.846,168.886,174.705,180.805,182.845,185.738,190.778,194.712,200.26,205.037,207.077,213.176,216.536,220.962,225.738,228.631,231.571,233.611,236.504,242.052,250.877,256.875,262.684,268.132,276.957,281.997,283.977,286.916,292.736,294.716,299.833,304.813,309.793,314.833,317.293,319.333,327.701,333.544,336.47,340.93,346.773,348.813,357.575,362.374,367.395,373.155,377.356,379.396,382.635,388.454,393.475,396.714,398.754,405.834,413.575,420.28,422.32,428.382,430.422,433.66,439.48,444.291,448.26,453.281,459.28,464.799,466.839,472.681,477.702,483.764,485.805,491.286,494.586,497.934,500.861,505.242,508.182,513.162,516.102,518.982,524.5" y="553.687" svg_rhmargin="527.005" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">patients with ALL and large B-cell lymphoma in 2017, which means that CAR T therapy had officially </text>
  <text x="82.273,87.077,95.928,100.732,104.694,110.269,115.072,121.199,123.704,124.259,129.273,133.525,136.03,136.585,141.565,144.07,144.686,148.647,153.451,159.026,161.946,170.798,175.601,181.437,183.942,184.497,187.838,193.313,197.275,199.78,200.335,203.573,209.633,218.485,223.96,227.922,230.427,231.042,237.068,242.082,245.32,248.26,253.064,258.823,262.062,266.323,268.828,269.444,272.363,278.199,280.704,281.319,284.558,290.377,295.181,297.686,298.301,302.754,305.634,308.554,314.389,317.269,321.711,324.22,326.725,327.34,333.487,339.322,342.242,346.495,349.0,349.555,355.681,360.484,364.937,369.917,375.978,380.778,383.287,385.792,386.407,391.421,393.926,394.481,397.401,402.876,406.115,408.62,409.235,414.71,418.05,420.555,421.171,425.552,428.472,431.392,437.152,440.071,444.524,449.504,452.444,454.949,455.564,458.803,462.763,465.642,470.683,473.562,477.824,480.329,480.944,484.906,489.71,495.228,500.268,504.23,510.291,513.211,518.97,524.488" y="567.187" svg_rhmargin="526.993" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">emerged as a regimen for tumor patients in the clinic. This decade, a lot of clinical trials regarding </text>
  <text x="82.273,89.369,97.157,103.842,106.347,108.222,114.356,116.86099999999999,118.736,121.994,127.818,132.609,136.509,141.511,147.525,153.088,155.593,157.468,165.817,170.608,174.558,179.298,181.803,183.677,188.059,193.099,197.049,200.949,203.857,208.648,214.709,217.214,219.089,224.552,230.586,233.764,236.269,238.144,243.146,247.046,252.509,258.543,264.367,270.481,272.986,274.86,278.119,283.943,288.682,291.187,293.062,301.41,306.873,310.823,313.731,319.793,322.273,324.778,326.593,334.361,338.583,341.088,342.962,348.406,351.716,354.221,356.096,363.864,369.859,373.79,376.73,379.618,382.123,383.998,388.981,394.021,396.499,399.004,400.819,405.802,410.842,415.825,420.865,423.343,425.848,427.722,430.962,436.767,441.539,444.044,445.919,448.859,454.618,457.978,463.439,467.37,476.131,481.171,484.41,487.35,492.75,498.555,501.06,502.935,506.294,510.194,515.638,524.459" y="580.687" svg_rhmargin="526.964" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">CAR T therapy were carried out around the world. As of April 19, 2018, the information from </text>
  <text x="82.273,89.386,92.311,95.236,101.077,104.001,108.383,113.363,116.303,119.541,123.501,128.481,131.406,134.331,138.532,140.992,146.57,152.05,157.721,160.721,164.978,170.819,176.299,184.664,189.473,195.604,198.604,201.783,207.602,212.621,215.86,218.86,227.716,233.196,237.163,241.972,244.972,248.21,254.03,259.01,264.829,267.829,272.809,277.828,282.847,285.847,292.867,300.669,307.371,310.273,316.335,319.635,323.605,328.416,331.296,336.336,339.575,344.374,350.508,353.508,357.769,361.007,367.061,373.123,376.05,380.791,385.051,388.051,396.42,401.232,405.202,410.013,412.953,419.007,424.851,430.985,435.797,439.697,445.275,450.758,453.685,459.529,465.112,468.112,472.494,475.422,478.35,484.109,487.037,491.419,496.441,499.321,502.321,505.559,509.519,512.447,517.427,520.355,524.556" y="594.187" svg_rhmargin="527.061" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">Clinicaltrails.gov showed that more than 270 CAR T-related studies were undergoing clinical trials </text>
  <text x="82.273,85.194,91.03,93.535,94.751,103.604,108.619,114.455,120.031,122.536,123.752,129.814,132.754,136.053,139.353,144.153,148.115,152.92,158.757,161.995,164.5,165.716,170.169,175.645,181.692,187.529,190.768,194.728,197.607,202.407,206.66,209.17,211.67499999999998,212.891,218.952,223.992,228.245,233.05,239.177,241.682,242.898,248.374,254.21,256.71500000000003,257.871,261.109,266.929,271.733,274.238,275.454,279.908,282.828,285.749,291.586,294.507,298.888,303.904,306.824,309.329,310.545,315.946,322.006,325.244,329.686,335.162,344.014,348.819,353.073,355.578,356.793,362.269,365.611,368.116,369.331,376.351,384.153,390.851,393.356,394.571,400.719,403.224,404.439,407.678,413.497,418.302,422.265,427.28,433.219,438.795,441.305,443.81,445.025,449.279,454.083,459.75,464.554,468.454,473.494,476.415,478.92,480.075,482.996,491.757,497.785,503.26,507.223,510.462,515.477,521.313,524.552" y="607.627" svg_rhmargin="527.057" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">in many different countries. Based on the clinical outcomes of CAR T therapy, several important </text>
  <text x="82.273,85.603,90.606,95.047,98.307,103.771,107.722,111.963,114.46799999999999,116.644,124.993,129.786,133.737,138.477,140.982,143.097,146.427,151.891,157.926,163.751,169.812,172.332,174.837,177.012,182.576,187.977,191.928,194.433,196.608,201.348,206.507,211.51,220.351,226.366,229.274,234.067,236.565,239.07,241.245,244.154,247.484,249.989,252.164,255.424,261.183,265.976,268.481,270.656,276.671,281.674,284.934,287.842,292.635,298.46,301.719,306.013,308.518,310.693,318.973,321.853,325.113,330.937,333.442,335.618,341.442,346.235,355.075,360.078,363.338,368.802,371.711,377.175,382.739,385.648,390.089,392.594,394.77,403.531,408.571,411.48,414.389,419.953,425.712,430.715,436.54,440.982,443.891,448.683,452.925,455.43,457.605,463.666,466.606,472.721,475.226,477.402,483.226,488.69,491.868,494.373,496.549,501.552,505.994,510.436,515.228,521.243,524.503" y="621.127" svg_rhmargin="527.008" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">factors were found. For example, if the patients with hematologic malignancies did not accept </text>
  <text x="82.273,85.213,90.791,99.619,105.621,111.432,116.883,122.985,127.765,133.767,136.707,141.486,144.733,147.673,153.133,158.945,161.45,162.005,167.526,172.306,175.665,181.126,185.064,189.844,192.349,192.904,196.15,200.088,204.868,209.908,213.154,221.982,226.761,232.573,235.82,238.325,238.88,247.216,250.156,253.403,259.214,261.719,262.274,269.358,277.134,283.807,286.312,286.867,292.99,295.495,296.05,300.479,305.258,308.198,311.078,315.306,317.713,320.218,320.773,324.039,329.869,334.668,340.238,342.743,343.298,351.654,357.055,363.096,366.01,372.071,375.071,379.319,385.36,388.696,392.031,396.83,400.73,403.235,403.79,409.45,414.249,418.206,423.724,426.229,426.784,431.031,435.771,439.728,442.642,448.112,454.153,458.401,460.906,461.461,468.481,475.201,480.461,482.966,483.521,488.53,494.289,500.411,502.916,503.471,508.269,513.93,518.728,524.488" y="634.627" svg_rhmargin="526.993" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">lymphodepletion before treatment with CAR T cells, they would suffer very serious CRS and even </text>
  <text x="82.273,85.187,88.101,91.435,96.233,99.568,102.832,108.662,112.618,117.358,122.366,125.631,130.428,136.258,139.172,145.001,150.57,152.91,157.708,163.367,168.164,173.994,177.259,181.505,184.008,186.348,194.627,200.028,208.383,213.18,218.84,223.637,227.593,230.096,232.436,235.7,241.53,246.328,250.283,255.081,257.361,260.274,264.521,266.861,271.107,274.372,277.285,280.199,283.113,285.453,291.282,296.751,299.031,303.277,308.773,313.022,316.288,321.029,329.85,334.86,338.127,341.043,345.491,347.831,351.789,356.589,362.169,365.109,369.908,378.265,380.544,386.015,389.352,391.692,394.958,400.79,405.589,407.929,412.729,416.065,419.402,422.318,426.699,431.74,436.188,441.706,444.046,449.056,454.888,461.01,463.291,467.539,472.549,475.886,480.685,483.952,489.523,491.863,497.263,500.623,502.903,510.007,517.802,524.496" y="648.127" svg_rhmargin="527.001" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">life-threatening events. However, there is still no systematic review of the efficacy and safety of CAR </text>
  <text x="82.273,88.395,90.735,93.981,99.793,104.573,108.51,113.55,119.549,125.1,127.44,130.38,136.14,138.419,144.421,149.461,152.708,155.647,160.427,166.239,169.485,173.714,176.053,184.39,187.33,190.576,196.388,198.667,204.77,207.709,211.026,214.386,219.165,223.103,227.883,233.694,236.941,239.28,242.459,248.519,257.346,262.797,266.735" y="661.627" svg_rhmargin="270.983" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">T therapy in patients with different tumors</text>
  <text x="271.093" y="661.627" svg_rhmargin="273.598" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.02px;font-style:ITALIC;font-weight:normal;">.</text>
  <text y="661.627" svg_rhmargin="365.273" x="275.953,282.106,287.865,293.918,298.12,300.636,302.975,306.214,312.034,314.913,319.175,321.514,325.774,329.012,335.012,341.134,346.653,348.992,352.292,355.219,358.146,361.025" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">Thus, this study fills</text>
  <text y="661.627" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.02px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="367.798" x=""/>
  <text x="367.633,370.811,376.631,379.57,383.832,386.172,391.629,394.569,399.609,405.369,410.919,413.199,416.558,422.019,425.956,428.296,431.541,437.352,442.13,444.47,447.786,450.725,454.662,458.89,462.135,464.475,467.653,470.593,479.42,484.198,486.538,491.996,497.574,499.914,505.935,510.162,513.102,518.861,524.411" y="661.627" svg_rhmargin="526.916" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">this blank for the first time by using </text>
  <text x="82.273,91.105,95.888,99.139,104.179,107.499,112.539,118.355,123.349,126.249,131.804,136.036,138.936" y="675.127" svg_rhmargin="143.184" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">meta-analysis</text>
  <text x="143.173,145.693" y="675.127" svg_rhmargin="148.198" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.02px;font-style:ITALIC;font-weight:normal;">, </text>
  <text x="148.213,152.414,158.474,163.992,169.57,173.537,179.017,185.068,191.067,193.527,198.546,204.306,209.325,212.249,217.767,222.029,224.909,229.17,231.63,236.649,242.49,248.621,251.141,259.963,264.702,267.941,272.981,276.326,280.293,285.102,290.62,294.587,299.395,303.597,307.858,310.783,316.263,322.104,324.564,329.583,335.423,340.403,343.343,348.861,353.123,356.047,360.249,362.709" y="675.127" svg_rhmargin="365.214" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">subgroup analysis and meta-regression analysis. </text>
  <text x="103.512,109.642,115.22,118.039,123.056,128.895,133.875,136.815,142.333,147.373,150.296,156.055,161.633,164.453,167.691,173.511,178.318,181.197,189.08,195.74,202.441,205.26,210.277,216.116,222.177,224.997,232.077,238.797,245.458,248.337,253.815,257.115,259.995,267.075,274.816,281.517,284.336,290.486,293.365,296.604,302.423,307.23,311.195,316.212,322.211,327.729,330.613,333.552,339.312,342.132,348.137,353.177,356.426,359.366,364.149,369.963,373.213,377.444,380.324,388.663,391.603,394.853,400.667,403.487,409.592,412.532,415.852,419.211,423.994,427.935,432.717,438.532,441.781,444.661,447.84,453.9,462.73,468.184,472.125,476.356,478.844,481.724,490.064,494.846,497.666,501.026,506.487,512.512,518.326,524.431" y="688.567" svg_rhmargin="526.936" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">By analyzing the ORR and CRR of CAR T therapy in patients with different tumors, we found </text>
  <text x="82.273,85.518,91.329,96.369,99.608,101.947,105.193,111.003,115.782,118.121,122.058,126.837,131.064,137.065,142.515,148.326,152.553,157.332,159.671,163.608,168.648,171.894,176.672,179.012,187.348,192.337,196.564,198.904,203.131,206.071,211.621,217.432,220.326,223.686,226.626,231.008,236.048,241.867,245.113,248.053,253.603,255.943,261.753,264.693,270.243,276.054,280.832,284.769,287.049,290.408,295.993,299.927,302.267,308.206,313.246,316.489,319.382,324.159,329.967,333.211,337.436,339.776,348.109,351.049,354.293,360.101,362.441,368.25,373.026,381.851,386.891,390.134,395.582,398.522,403.983,409.531,412.471,416.897,419.236,428.061,433.048,435.988,438.928,444.506,450.314,455.354,461.163,465.589,468.529,473.328,477.554,479.893,484.319,489.767,498.592,504.591,509.631,513.591,518.367,524.466" y="702.067" svg_rhmargin="526.971" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">that the response rate was significantly higher for patients with hematologic malignancies compared </text>
  <text x="82.273,85.522,90.976,93.481,94.036,100.041,105.081,108.331,111.271,116.053,121.868,125.117,129.349,131.85399999999998,132.409,140.749,143.647,146.897,152.712,155.21699999999998,155.772,160.003,165.457,168.397,171.277,177.382,179.887,180.442,189.203,194.243,197.142,200.041,205.595,211.41,216.45,222.264,226.696,229.636,234.436,238.667,241.155,243.66,244.215,250.25,254.191,258.974,264.618,267.558,273.019,279.044,283.275,285.78,286.335,290.567,293.773,299.815,305.877,308.793,313.593,317.794,320.299,320.854,325.103,331.103,336.674,342.245,347.044,351.293,354.559,359.359,365.42,367.925,368.48,371.747,377.578,382.588,385.855,388.36,388.915,396.019,403.761,410.454,412.959,413.514,419.656,422.161,422.717,425.983,431.815,436.555,440.515,445.525,451.547,457.118,460.118,464.367,467.633,470.549,473.465,476.381,478.88599999999997,479.441,485.2,490.24,496.301,498.806,499.362,508.209,513.219,519.051,524.51" y="715.567" svg_rhmargin="527.015" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">to patients with solid malignancies. Previous studies suggested that CAR T therapy still had many </text>
  <text x="82.273,88.272,92.232,97.71,103.228,106.151,110.957,119.779,124.04,126.545,128.06,133.077,138.837,144.966,147.471,149.046,153.502,159.341,164.321,167.261,170.14,174.94,180.779,186.357,191.163,195.365,197.87,199.385,202.728,208.206,212.171,214.676,216.251,222.19,227.23,230.469,233.409,238.215,244.054,247.292,251.494,253.999,255.514,263.877,266.8,270.039,275.858,278.363,279.938,284.194,289.595,292.518,295.44,301.501,304.006,305.582,314.343,319.383,322.263,325.203,330.781,336.54,341.557,347.396,351.852,354.775,359.514,363.776,366.236,368.741,370.316,374.517,380.577,385.033,390.872,393.377,394.892,399.909,404.11,406.615,408.19,413.207,419.046,422.284,425.164,430.742,435.482,441.32,443.825,445.401,451.041,456.021,458.944,461.866,467.928,472.945,476.183,479.106,484.584,490.422,492.882,495.387,496.962,500.201,506.261,515.083,520.544,524.508" y="729.067" svg_rhmargin="527.013" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">problems and challenges for patients with solid malignancies, such as antigen validation, tumor </text>
  <text x="82.273,85.511,89.471,94.485,97.826,101.126,104.065,108.518,114.036,116.956,122.792,128.31,130.815,132.99,137.97,143.79,149.916,152.421,154.596,157.516,163.276,166.616,169.496,172.416,175.654,179.616,184.63,187.869,190.809,196.209,202.029,204.538,207.043,209.218,212.457,218.517,227.369,232.843,236.743,239.248,241.424,247.259,252.063,255.301,260.101,264.063,269.538,275.113,279.916,285.752,290.492,293.411,296.65,302.225,304.734,307.239,309.354,314.334,320.154,326.28,328.78499999999997,330.96,335.974,341.734,344.239,346.414,349.334,358.186,366.947,372.947,378.783,384.258,388.51,394.556,400.582,406.608,410.57,415.374,419.575,423.828,426.748,432.328,437.127,439.632,441.808,450.659,453.579,458.032,461.994,467.469,472.272,478.108,483.688,486.608,490.508,495.983,501.818,510.67,515.474,521.309,524.548" y="742.566" svg_rhmargin="527.053" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">trafficking and infiltration, tumor heterogeneity, and an immunosuppressive microenvironment </text>
  <text x="82.273,85.619,90.599,95.618,98.077,103.057,108.097,110.557,115.597,120.577,123.937,126.451,128.956,132.751,138.813,144.632,149.441,153.699,158.507,161.012,164.807,170.806,174.766,180.245,185.764,188.643,193.384,202.205,206.467,208.972,212.766,217.785,223.626,229.688,232.19299999999998,235.988,240.446,246.205,251.224,254.104,257.029,261.837,267.678,273.258,277.999,282.26,284.765,288.56,291.439,296.239,302.37,304.875,308.67,311.848,317.293,319.798,323.593,329.594,335.043,340.493,344.43,346.935,350.73,354.667,359.445,363.673,369.674,375.124,380.934,385.162,389.94,392.445,396.24,400.177,405.217,408.462,413.241,415.746,419.54,424.99,428.306,430.811,434.605,440.606,445.646,448.892,451.832,456.61,462.421,465.666,469.894,472.399,476.193,484.529,487.424,490.669,496.48,498.985,502.779,507.007,512.457,515.397,518.276,524.378" y="756.066" svg_rhmargin="526.883" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.02px;font-style:NORMAL;font-weight:normal;">[27,66,67]. These problems and challenges led to poor response rate of patients with solid </text>
  <rect style="stroke:blue;stroke-width:0.3;" x="136.152" y="48.668" height="378.0" width="334.44" title="19"/>
  <text x="136.152" y="48.668" class="image" id="image.19.1" width="334" height="378">image.19.1.136_471.49_427</text>
  <text svg_rhmargin="133.365" x="97.795,102.78,105.766,110.751,116.23,119.718,124.20100000000001,126.64,131.123,133.36499999999998" y="442.329" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">Figure 5. </text>
  <text x="136.722,142.328,147.651,152.032,154.465,157.51,162.504,165.961,170.342,174.219,177.201,179.634,185.13,187.792,192.785,195.767,199.64499999999998,202.077,207.071,210.117,212.549,220.625,225.006,227.987,232.56,235.606,239.063,243.444,248.529,251.976,256.357,260.235,264.113,266.774,271.768,277.09099999999995,279.523,284.096,289.419,293.992,296.653,301.738,305.616,308.278,312.155,314.44199999999995,317.606" y="442.329" svg_rhmargin="320.652" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The forest plots of meta-regression analysis: (</text>
  <text x="320.656" y="442.329" svg_rhmargin="325.139" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">a</text>
  <text x="325.139,328.185,330.617,335.702,340.696,344.153,348.534,352.412,355.394,357.826,363.322,365.984,370.977,373.959,376.392,379.437,384.431,388.044,390.476,397.665,403.774,409.884,412.325,416.898,422.221,427.809,430.242,436.726,439.808,442.241,447.234,450.28,452.713,456.773,461.154,463.816,466.477,468.919,472.98,478.495,481.156,484.137,489.652,493.1" y="442.329" svg_rhmargin="497.481" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">) Forest plot for ORR and CI of cell culture</text>
  <text x="97.419,104.875,107.476,110.39,115.593,117.837,120.849,126.311,129.288,133.758,135.993,140.463,145.925,151.387,153.988,156.902,159.504,164.385,169.588,171.831,176.301,181.504,186.96599999999998,189.201,193.17,197.452,200.053,202.655,204.899,208.868,214.258,216.86,219.774,225.164,228.535,232.817,235.061,242.516,245.117,248.032,253.235,258.116,263.506,266.41999999999996,268.655,271.668,277.13,280.107,284.57700000000006,286.82,291.29,296.752,302.214,304.815,307.73,310.331,315.212,320.41499999999996,322.65,327.531,330.508,332.751,337.033,341.503,345.472,350.67499999999995,352.919,356.709,359.624,365.014,370.476,375.447,377.681,382.151,387.354,392.816,395.06,397.974,403.177,407.459,409.703,414.584,419.634,423.916,427.448,431.917,434.51,437.111,439.346,441.59" y="455.151" svg_rhmargin="444.567" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">with IL-2 addition and cell culture without IL-2 addition of each study and the overall; (</text>
  <text x="444.568" y="455.151" svg_rhmargin="450.046" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">b</text>
  <text x="450.046,453.02299999999997,455.267,460.237,465.118,468.488,472.77,476.561,479.47499999999997,481.71,487.082,489.684,494.565" y="455.151" svg_rhmargin="497.479" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">) Forest plot</text>
  <text x="97.795,100.721,105.519,108.99000000000001,111.125,117.355,123.225,129.095,131.23,135.623,140.737,146.106,148.242,154.472,157.43300000000002,159.568,164.366,167.292,169.427,172.292,177.406,181.615,183.75,186.615,191.412,194.277,198.671,201.22799999999998,203.363,207.756,213.125,220.884,223.441,228.555,231.112,234.838,237.703,241.174,245.567,248.432,250.989,255.787,260.901,263.036,268.405,273.203,276.928,281.137,283.272,291.031,295.829,299.142,303.351,305.486,308.351,313.465,317.858,322.972,325.108,329.501" y="467.972" svg_rhmargin="333.895" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">for CRR and CI of the total administration dose more than 10</text>
  <text svg_rhmargin="337.377" x="333.89,337.377" y="467.972" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:6.97px;font-style:NORMAL;font-weight:normal;">8 </text>
  <text x="340.011,343.912,348.121,350.678,353.236,356.962,359.096,363.49,368.604,373.97299999999996,376.108,378.665,382.874,386.6,390.326,392.461,395.326,400.44,404.833,409.947,412.082,416.476" y="467.972" svg_rhmargin="420.87" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cells and less than 10</text>
  <text svg_rhmargin="424.356" x="420.869,424.35600000000005" y="467.972" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:6.97px;font-style:NORMAL;font-weight:normal;">8 </text>
  <text x="426.989,430.89,435.099,437.657,440.214,443.94,446.075,450.872,453.798,455.934,460.143,464.536,468.438,473.55199999999996,475.687,479.413,482.277,487.576,492.945" y="467.972" svg_rhmargin="497.831" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cells of each study</text>
  <text x="97.795,102.278,107.497,112.975,115.217,118.14,123.358,127.653,129.895,134.79,139.856,144.151,147.693,152.176,154.785,157.395" y="480.794" svg_rhmargin="159.637" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">and the overall.</text>
  <text svg_rhmargin="129.492" x="97.499,102.484,106.968,112.446,115.432,119.915,122.766,127.25,129.492" y="508.756" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">Table 3. </text>
  <text x="134.094,139.7,145.023,149.404,152.257,155.705,160.086,163.964,169.479,172.14,175.12199999999999,177.966,182.96,186.006,188.859,196.934,201.315,204.297,208.869,211.915,215.363,219.744,224.829,228.286,232.667,236.544,240.422,243.084,248.077,253.4,256.244,260.817,266.14,270.713,273.374,278.459,282.337,284.999,288.877,291.73,296.303,301.36,306.354,311.869,314.85100000000006,317.694,320.676,325.999,330.38,333.233,337.806,341.684,345.561,350.555,354.616,357.277,361.85,364.832,367.493,372.486,377.80899999999997,380.654,385.711,390.092,393.074,400.701,405.082,409.463,414.786,417.639,420.62,425.943,430.32399999999996,433.168,437.229,442.552,447.125,450.737,455.31,459.371,462.352,466.733,470.346,473.007,476.885,479.866,482.528,486.589,489.442,494.436" y="508.756" svg_rhmargin="497.482" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The result of meta-regression analysis about the association between the characteristic of</text>
  <text x="97.795,101.776,106.672,111.89,116.786,120.328,123.251,127.05300000000001,129.294,133.777,138.996,144.47400000000002,146.716,149.639,154.857,159.152,161.394,166.872,169.481,172.306,175.292,179.587,182.967,187.262,192.48,196.461,200.756,202.998,206.54,211.023,213.946,218.241,222.043,224.284,226.893,232.112,236.093,238.702,244.109,249.587,253.882,259.36,261.602,264.211,269.42900000000003,271.671,274.595,279.813,282.422,286.22400000000005,288.466,292.267,295.19,300.597,306.076,308.685,312.98,316.781" y="521.578" svg_rhmargin="319.023" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">cohorts and the difference rates included in this studies.</text>
  <text svg_rhmargin="168.278" x="136.896,142.357,146.45,149.635,152.361,156.455,161.457,164.184,168.277" y="541.6800000000001" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">Variable </text>
  <text x="346.497" y="541.6800000000001" svg_rhmargin="351.049" style="fill:#000000;font-family:WBVKDJ+URWPalladioL-BoldItal;font-size:8.97px;font-style:italic;font-weight:BOLD;">p</text>
  <text x="210.362,217.182,221.734,225.828,229.013,233.106,235.832,238.558,240.606,246.517,250.61,254.246,259.248,263.8,268.802,272.438,276.531,289.017,294.928,299.48,306.758,311.761,314.487,318.581,321.307,325.40000000000003,327.448,333.359,337.452,341.087,346.09,350.642,355.644,359.279,363.372,380.804,386.715,392.626,397.628,418.964,425.784,430.786,452.409,458.32,462.414,465.14,469.234,474.236,477.871" y="556.116" svg_rhmargin="481.965" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">Overall Response Complete Response CRS NS Relapse</text>
  <text x="107.069,113.315,117.237,122.002,125.924,129.158,133.251,135.92,138.303,142.773,147.53799999999998,149.585,154.055,156.781,158.828,164.633,171.003,176.47199999999998,232.186,236.279,238.326,242.42,246.513,250.607,254.7,314.934,319.027,321.074,325.168,329.262,333.355,337.44800000000004,377.959,382.053,384.1,388.193,392.287,396.38,400.473,423.513,426.239,455.926,460.02,462.066,466.16,470.254,474.347" y="570.552" svg_rhmargin="478.441" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Generation of CAR 0.2949 0.4523 0.5202 - 0.9884</text>
  <text svg_rhmargin="400.474" x="107.069,112.071,115.993,119.628,122.297,126.767,130.001,232.186,236.279,238.326,242.42,246.513,250.607,254.7,314.934,319.027,321.074,325.168,329.262,333.355,337.44800000000004,377.959,382.053,384.1,388.193,392.287,396.38,400.473" y="580.605" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Vector 0.9289 0.8990 0.0748 </text>
  <text svg_rhmargin="436.58" x="414.515,418.526,420.532,424.544,428.556,432.568,436.58" y="580.605" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">0.2253 </text>
  <text x="455.926,460.019,462.066,466.16,470.253,474.347" y="580.605" svg_rhmargin="478.441" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">0.2467</text>
  <text svg_rhmargin="400.474" x="107.068,112.873,116.795,119.177,121.55900000000001,123.607,127.242,132.179,134.561,137.23,142.167,145.254,149.176,151.222,153.891,156.274,163.503,167.42499999999998,232.186,236.279,238.326,242.42,246.513,250.607,254.7,314.934,319.027,321.074,325.168,329.262,333.355,337.44800000000004,377.959,382.053,384.1,388.193,392.287,396.38,400.473" y="590.657" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Cell culture time 0.8076 0.7688 0.1466 </text>
  <text svg_rhmargin="436.58" x="414.515,418.526,420.532,424.544,428.556,432.568,436.58" y="590.657" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">0.2253 </text>
  <text x="455.926,460.019,462.066,466.16,470.253,474.347" y="590.657" svg_rhmargin="478.441" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">0.8455</text>
  <text svg_rhmargin="400.474" x="107.068,111.35,114.584,118.678,123.443,126.914,129.641,133.562,137.197,139.867,142.249,146.719,151.48399999999998,153.531,160.76,164.682,167.351,172.116,176.586,181.58800000000002,232.186,236.279,238.326,242.42,246.513,250.607,254.7,314.934,319.027,321.074,325.168,329.262,333.355,337.44800000000004,377.959,382.053,384.1,388.193,392.287,396.38,400.473" y="600.7090000000001" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Transfection method 0.5534 0.1119 0.4349 </text>
  <text svg_rhmargin="436.58" x="414.515,418.526,420.532,424.544,428.556,432.568,436.58" y="600.7090000000001" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">0.2253 </text>
  <text x="455.926,460.019,462.066,466.16,470.253,474.347" y="600.7090000000001" svg_rhmargin="478.441" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">0.6129</text>
  <text svg_rhmargin="400.474" x="107.068,109.828,114.83,117.556,121.649,123.697,127.79,132.793,137.795,140.178,142.847,145.229,149.699,154.464,232.186,236.279,238.326,242.42,246.513,250.607,254.7,314.934,319.027,321.074,325.168,329.262,333.355,337.44800000000004,377.959,382.053,384.1,388.193,392.287,396.38,400.473" y="610.761" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">IL-2 addition 0.0176 0.1119 0.7218 </text>
  <text svg_rhmargin="436.58" x="414.515,418.526,420.532,424.544,428.556,432.568,436.58" y="610.761" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">0.2253 </text>
  <text x="455.926,460.019,462.066,466.16,470.253,474.347" y="610.761" svg_rhmargin="478.441" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">0.6129</text>
  <text x="107.068,112.014,115.935,119.169,122.641,125.023,128.494,131.163,135.085,139.85,143.485,147.407,232.186,236.279,238.326,242.42,246.513,250.607,254.7,314.934,319.027,321.074,325.168,329.261,333.355,337.44800000000004,377.959,382.053,384.099,388.193,392.287,396.38,400.473,423.513,426.239,455.926,460.02,462.066,466.16,470.254,474.347" y="620.813" svg_rhmargin="478.441" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Persistence 0.4836 0.5633 0.2279 - 0.8455</text>
  <text x="107.068,111.621,116.173,123.402,128.323,133.087,137.558,142.56,146.482,151.402,153.785,157.706,160.376,162.758,167.228,171.993,232.186,236.279,238.326,242.42,246.513,250.607,254.7,314.934,319.027,321.074,325.168,329.262,333.355,337.44800000000004,377.959,382.053,384.1,388.193,392.287,396.38,400.473,423.513,426.239,455.926,460.02,462.066,466.16,470.254,474.347" y="630.865" svg_rhmargin="478.441" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Lymphodepletion 0.9053 0.9938 0.3513 - 0.6129</text>
  <text svg_rhmargin="400.469" x="107.069,111.275,115.691,118.328,122.373,124.727,126.757,130.802,135.744,142.886,145.24,149.948,152.302,155.732,158.369,161.564,165.608,168.245,170.599,175.016,179.724,181.762,186.704,191.121,194.551,198.426,232.189,236.282,238.329,242.423,246.516,250.61,254.703,314.937,319.031,321.077,325.171,329.265,333.358,337.451,377.954,382.048,384.095,388.188,392.282,396.375,400.468" y="640.918" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">Total administration dose 0.2022 0.0067 0.1466 </text>
  <text svg_rhmargin="436.58" x="414.515,418.526,420.532,424.544,428.556,432.568,436.58" y="640.918" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">0.1573 </text>
  <text x="455.926,460.019,462.066,466.16,470.253,474.347" y="640.918" svg_rhmargin="478.441" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">0.6129</text>
  <text x="76.535,81.516,84.007,87.095,95.394,98.712,103.135,107.559,113.646,118.069,122.492,125.81,131.349" y="667.577" svg_rhmargin="137.436" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:9.96px;font-style:NORMAL;font-weight:BOLD;">3. Discussion</text>
  <text x="97.795,105.391,109.531,111.561,116.892,122.574,127.25,129.282,134.613,137.864,139.895,143.077,148.76,153.43599999999998,155.467,164.088,169.419,173.559,176.742,178.772,184.64,188.311,193.642,202.263,205.104,209.244,212.085,217.767,223.195,225.226,228.409,232.09,236.767,241.648,244.831,253.452,258.129,263.811,266.994,271.134,273.164,276.415,281.746,285.602,287.634,290.816,296.704,305.325,310.655,314.512,318.652,321.09299999999996,323.211,326.394,334.537,339.868,341.898,347.327,350.168,355.85,361.815,365.955,367.986,373.317,376.568,378.599,385.521,393.117,399.639,401.669,407.654,409.685,412.868,418.55,423.227,427.083,431.965,437.833,443.261,445.292,448.543,453.981,456.822,460.962,465.844,471.272,475.949,481.631,484.472,489.149,493.484,496.325,501.002,506.889,511.224,515.901" y="687.064" svg_rhmargin="518.742" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">As one of the most promising treatments for tumors, two kinds of CAR T therapy (Tisagenlecleucel</text>
  <text x="76.535,81.616,87.53,93.739,96.219,102.082,106.949,111.258,115.77,120.851,124.865,128.178,133.258,136.642,139.112,145.026,150.107,156.316,158.795,164.415,169.282,174.15,180.064,182.543,187.624,193.732,199.839,203.67,209.218,214.96,219.827,226.036,228.516,234.135,239.785,242.265,245.577,251.492,256.36,258.828,264.478,270.027,275.575,281.784,284.264,289.345,295.259,301.468,303.947,311.812,315.745,321.873,327.52299999999997,330.002,337.908,344.117,353.09,356.047,361.961,364.918,369.227,372.54,376.553,381.634,384.947,387.904,393.453,399.36699999999996,401.836,405.22,410.768,414.782,417.262,423.369,428.45,431.763,434.72,439.587,445.502,448.814,453.12300000000005,455.603,464.077,467.035,470.347,476.26099999999997,478.731,486.637,492.846,499.055,501.534,506.615,512.529" y="700.574" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">and Yescarta) had been approved by the Food and Drug Administration for patients with ALL and</text>
  <text x="76.535,79.417,84.368,88.101,93.607,98.351,100.846,106.897,110.195,114.592,119.335,122.217,125.099,127.584,130.466,135.972,144.716,150.668,156.431,161.838,170.582,175.534,178.029,180.911,186.675,189.17,194.121,199.073,204.024,208.975,211.451,213.947,222.206,227.969,230.851,235.248,241.012,243.507,252.251,256.994,261.946,267.709,271.908,274.403,277.632,283.395,288.347,291.575,294.061,301.082,308.786,315.401,317.897,323.968,326.463,329.691,335.454,340.198,344.109,349.061,355.012,360.51800000000003,363.014,368.777,373.729,379.78,382.265,387.672,390.791,396.783,401.179,404.061,409.013,411.894,414.776,420.28200000000004,422.777,427.521,436.265,441.009,444.742,450.248,454.991,461.042,463.537,468.489,472.688,475.183,480.135,482.63,486.354,491.097,496.603,499.485,508.229,512.972" y="714.083" svg_rhmargin="518.735" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">large B-cell lymphoma in 2017, which means that CAR T therapy had ofÔ¨Åcially emerged as a regimen</text>
  <text x="76.535,79.919,85.467,89.481,92.499,95.802,101.929,110.902,116.451,120.46499999999999,123.483,129.59,134.671,137.984,140.941,145.808,151.723,155.035,159.344,162.352,165.309,171.22299999999998,174.241,177.554,183.468,188.33599999999998,191.344,195.855,198.813,201.77,207.684,210.641,215.153,217.694,222.347,228.577,234.491,237.448,241.757,244.775,250.983,255.851,260.363,265.444,271.653,276.52,279.061,282.201,287.28200000000004,290.3,293.257,298.805,302.118,305.126,310.674,314.058,317.076,321.588,324.545,327.492,333.406,336.363,340.875,345.956,348.913,351.931,355.244,359.258,362.215,367.296,370.253,374.562,377.57,381.411,386.278,391.928,397.009,400.84,407.049,410.006,415.92,421.57,424.589,431.793,439.699,446.487,449.495,455.724,458.732,462.045,467.959,472.827,476.841,481.922,488.029,493.679,496.697,505.172,510.039,513.87" y="727.592" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">for tumor patients in the clinic. This decade, a lot of clinical trials regarding CAR T therapy were</text>
 </g>
</svg>
